Latest Videos

What’s better at finding a hidden bomb - a dog, or an electronic chemical detector? Let’s find out.

In this episode we will be speaking with Professor Bissan Al-Lazikani, from the Institute of Cancer Research about how data science and machine learning approaches are used for cancer drug discovery and treatment adaptation.

Join this Teach Me in 10 session to hear Corning Life Sciences application scientists walk you through common research goals and the most suitable 3D cell culture solutions for each.

In this episode we will be speaking with Professor Tony Whetton, the Director of the Stoller Biomarker Discovery Centre about biomarkers for cancer research and their importance.

Experts Ron McNaughton, head of the Scottish Food Crime and Incidents Unit at Food Standards Scotland, and Chris Elliott, professor of food security at Queen's University Belfast and director of the Institute for Global Food Safety, took part in a joint question and answer interview tackling a variety of food crime issues.

Several European countries have temporarily halted the administration of the Oxford–AstraZeneca COVID-19 vaccine, ChAdOx1, after reports of thrombotic events occurring in individuals that had previously received the vaccine. In this video interview, we speak with Dr Andrew Preston, reader in Microbial Pathogenesis at the University of Bath, to learn more about the situation and its potential implications for global vaccination strategies.

The shared CD25 activation mechanism on regulatory and effector T cells has been a big challenge when designing immunotherapy drugs. Now, researchers have developed a new antibody that can target CD25 specifically on regulatory T cells while leaving effector T cells intact.

In this episode we will be speaking with Hashem Al-Ghaili, Molecular Biotechnologist and Science Communicator about the use of CRISPR in cancer.

The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists.

In this episode we will be speaking with Dr Clare Turnbull from The Institute of Cancer Research about the genetics of cancer.